相似文献
1
Combined in vitro effect of amphotericin B and rifampin on Cryptococcus neoformans.
Antimicrob Agents Chemother. 1981 Jan;19(1):196-8. doi: 10.1128/AAC.19.1.196.
2
Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi. 1982 May;15(2):106-12.
3
Combination of amphotericin B with flucytosine is active in vitro against flucytosine-resistant isolates of Cryptococcus neoformans.
Antimicrob Agents Chemother. 2007 Jan;51(1):383-5. doi: 10.1128/AAC.00446-06. Epub 2006 Oct 16.
4
Effect of ketoconazole and amphotericin B on encapsulated and non-encapsulated strains of Cryptococcus neoformans.
Antimicrob Agents Chemother. 1983 Dec;24(6):851-5. doi: 10.1128/AAC.24.6.851.
5
Antifungal drug combinations for Cryptococcus neoformans and Prototheca spp.
J Med Assoc Thai. 2000 Jan;83(1):57-60.
6
[Research in vitro on the anticryptococcal effects of various steroid hormones alone or in combination with antifungal agents].
Pathologica. 1976 Nov-Dec;68(985-986):547-60.
7
In vitro synergistic effects of chlorpromazine and sertraline in combination with amphotericin B against Cryptococcus neoformans var. grubii.
Folia Microbiol (Praha). 2016 Sep;61(5):399-403. doi: 10.1007/s12223-016-0449-8. Epub 2016 Feb 4.
8
Combined effect of amphotericin B and rifampin on Candida species.
Antimicrob Agents Chemother. 1980 Mar;17(3):484-7. doi: 10.1128/AAC.17.3.484.
9
Evaluation of Mycograb, amphotericin B, caspofungin, and fluconazole in combination against Cryptococcus neoformans by checkerboard and time-kill methodologies.
Diagn Microbiol Infect Dis. 2005 Jan;51(1):19-29. doi: 10.1016/j.diagmicrobio.2004.08.013.
10
Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro.
Antimicrob Agents Chemother. 1997 Feb;41(2):331-6. doi: 10.1128/AAC.41.2.331.
引用本文的文献
1
Rifampin combination therapy for nonmycobacterial infections.
Clin Microbiol Rev. 2010 Jan;23(1):14-34. doi: 10.1128/CMR.00034-09.
2
Antifungal activity of nonantifungal drugs.
Eur J Clin Microbiol Infect Dis. 2003 Jul;22(7):397-407. doi: 10.1007/s10096-003-0947-x. Epub 2003 Jun 26.
3
In vitro susceptibilities of zygomycetes to combinations of antimicrobial agents.
Antimicrob Agents Chemother. 2002 Aug;46(8):2708-11. doi: 10.1128/AAC.46.8.2708-2711.2002.
4
Inhibition of RNA synthesis as a therapeutic strategy against Aspergillus and Fusarium: demonstration of in vitro synergy between rifabutin and amphotericin B.
Antimicrob Agents Chemother. 1998 Mar;42(3):509-13. doi: 10.1128/AAC.42.3.509.
5
Effects of naftifine and terbinafine, two allylamine antifungal drugs, on selected functions of human polymorphonuclear leukocytes.
Antimicrob Agents Chemother. 1994 Nov;38(11):2605-11. doi: 10.1128/AAC.38.11.2605.
6
Novel synergism of two antifungal agents, copiamycin and imidazole.
Antimicrob Agents Chemother. 1983 Oct;24(4):552-9. doi: 10.1128/AAC.24.4.552.
7
Synergistic action of amphotericin B and rifampin against Rhizopus species.
Antimicrob Agents Chemother. 1987 Nov;31(11):1775-8. doi: 10.1128/AAC.31.11.1775.
8
Treatment of systemic fungal infections: recent progress and current problems.
Eur J Clin Microbiol Infect Dis. 1988 Aug;7(4):460-75. doi: 10.1007/BF01962595.
9
In vitro and in vivo evaluation of antifungal agents.
Eur J Clin Microbiol Infect Dis. 1989 Apr;8(4):352-61. doi: 10.1007/BF01963469.
本文引用的文献
1
Combined effect of amphotericin B and rifampin on Candida species.
Antimicrob Agents Chemother. 1980 Mar;17(3):484-7. doi: 10.1128/AAC.17.3.484.
2
Amphotericin B potentiation of rifampicin as an antifungal agent against the yeast phase of Histoplasma capsulatum.
Science. 1972 Aug 25;177(4050):709-10. doi: 10.1126/science.177.4050.709.
3
Antituberculous activity of rifampin in vitro and in vivo and the concentrations attained in human blood.
Am Rev Respir Dis. 1968 Dec;98(6):923-32. doi: 10.1164/arrd.1968.98.6.923.
4
Rifampin concentrations in cerebrospinal fluid of patients with tuberculous meningitis.
Am Rev Respir Dis. 1974 May;109(5):579-80. doi: 10.1164/arrd.1974.109.5.579.
5
In vitro activity of ampicillin or vancomycin combined with gentamicin or streptomycin against enterococci.
Antimicrob Agents Chemother. 1973 Oct;4(4):383-7. doi: 10.1128/AAC.4.4.383.
6
Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism).
Proc Natl Acad Sci U S A. 1972 Jan;69(1):196-9. doi: 10.1073/pnas.69.1.196.
7
In vitro inhibition of Coccidioides immitis strains with amphotericin B plus rifampin.
Antimicrob Agents Chemother. 1974 Dec;6(6):783-4. doi: 10.1128/AAC.6.6.783.
8
Effect of amphotericin B and rifampin against Coccidioides immitis in vitro and in vivo.
Antimicrob Agents Chemother. 1976 Mar;9(3):406-13. doi: 10.1128/AAC.9.3.406.
9
Synergistic action of amphotericin B and rifampin against Candida species.
J Infect Dis. 1976 Feb;133(2):206-9. doi: 10.1093/infdis/133.2.206.
10
Therapy of cryptococcosis with a combination of flucytosine and amphotericin B.
J Infect Dis. 1975 Oct;132(4):368-73. doi: 10.1093/infdis/132.4.368.
Zotero 插件